CoreMap Inc.
This is a global, multi-site, prospective, feasibility study.
The INvENI Study consists of three phases: Phase 1, the goal is to collect and analyze high fidelity endocardial electrograms (EGMs) in patients with persistent AF (PerAF) and long-standing persistent AF and to demonstrate safety. Phase 2, the goal is the initial development and evaluation of a CoreMap-guided tailored ablation strategy and to demonstrate safety and effectiveness of the CoreMap EP Mapping System in patients with PerAF and long-standing persistent AF. Phase 3, the goal is to evaluate the safety and effectiveness of the CoreMap EP Mapping System's ability to identify spatially…
Inclusion Criteria: 1. Subject has persistent or long-standing persistent AF, at the discretion of the investigator (Phase 1 \& 2) 2. Subject has PerAF with no history of prior AF ablation therapy (Phase 3) 3. Subject is 18 to 80 years of age 4. Subject has presence of AF-related symptoms and is scheduled for clinically indicated standard of care AF ablation to manage PerAF (Phase 2 or 3) or long-standing PerAF (Phase 2) 5. Subject is able to provide written informed consent 6. Subject is able and willing to complete all study procedures Exclusion Criteria: 1. Any of the following within th…
Endocardial mapping to collect and analyze high fidelity endocardial EGMs in patients with persistent and long-standing persistent AF.
Initial development and evaluation of a map-guided tailored ablation strategy and to demonstrate safety and chronic efficacy of the CoreMap EP Mapping System.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.